ClinVar Miner

Submissions for variant NM_000350.3(ABCA4):c.926C>G (p.Pro309Arg)

gnomAD frequency: 0.00039  dbSNP: rs61748545
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000085874 SCV000321334 likely pathogenic not provided 2023-10-17 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25066811, 11527935, 19074458, 28041643, 32581362)
Blueprint Genetics RCV001075838 SCV001241477 likely pathogenic Retinal dystrophy 2019-08-01 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000085874 SCV001382437 pathogenic not provided 2024-12-31 criteria provided, single submitter clinical testing This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 309 of the ABCA4 protein (p.Pro309Arg). This variant is present in population databases (rs61748545, gnomAD 0.2%). This missense change has been observed in individual(s) with Stargardt disease (PMID: 25066811; internal data). ClinVar contains an entry for this variant (Variation ID: 99513). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ABCA4 protein function. For these reasons, this variant has been classified as Pathogenic.
Fulgent Genetics, Fulgent Genetics RCV005025170 SCV005658937 likely pathogenic Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 2024-03-28 criteria provided, single submitter clinical testing
Retina International RCV000085874 SCV000118017 not provided not provided no assertion provided not provided
NIHR Bioresource Rare Diseases, University of Cambridge RCV000504769 SCV000599027 likely pathogenic Macular dystrophy 2015-01-01 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.